Citius Pharmaceuticals Inc vs Dicks Sporting Goods Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Dicks Sporting Goods Inc trades at $206.29 (market cap $18.35B). The key difference: Dicks Sporting Goods Inc is far larger — about 917× Citius Pharmaceuticals Inc's market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | DKS | |
|---|---|---|
Market Cap | $20.01M | $18.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $239.17 |
52-Week Low | $0.48 | $187.78 |
Enterprise Value | $16.23M | $25.14B |
Dividend Yield | — | 2.44% |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →